Fundraising Fox

Leen Kawas

Investor

General Partner at Propel Bio Partners

Seattle, Washington

Writes $100K – $5M checks Β· typically $1.5M

About

Leen Kawas is co-founder and managing general partner at Propel Bio Partners, a biotech-focused fund supporting life science innovations. She moved to the US from Jordan in 2008, co-founded the company now known as LeonaBio, and became its CEO in 2014, advancing multiple late-stage clinical programs and taking the company public in 2020 with over $400 million raised. Her recognitions include the Life Science Entrepreneurial Achievement Award (2020), French-American Foundation Leader (2019), and GeekWire Startup CEO of the Year (2019).

Invests in

Biotech

Experience

  1. EIT Pharma, Inc.Chief Executive Officercurrent2026 β€” presentGreater Seattle Area
  2. Propel Bio Partners LLCManaging General Partnercurrent2021 β€” present
  3. WASHINGTON INNOVATION NETWORKMentorcurrent2024 β€” presentSeattle, Washington, United States
  4. Inherent Biosciences, Inc.Member Board of Directorscurrent2022 β€” presentSalt Lake County, Utah, United States
  5. Persephone BiosciencesMember Board Of Directorscurrent2022 β€” presentSan Diego Metropolitan Area
  6. TympanogenBoard Observer- Investorcurrent2023 β€” presentRichmond, Virginia, United States
  7. NOWDiagnostics | NOWDxBoard Observercurrent2023 β€” present
  8. NucleateAdvisor-Seattlecurrent2022 β€” present
  9. ChiefMembercurrent2022 β€” present
  10. Forbes Business CouncilMember2022 β€” 2025
  11. LeonaBioCEO & President2014 β€” 2021Greater Seattle Area
  12. LeonaBioVice President of Research2011 β€” 2014
  13. Washington State UniversityResearch Associate2013 β€” 2015spokane, washington area
  14. Pharmacy1, Amman JordanStaff Pharmacist2008Amman,Jordan
  15. University of Jordan HospitalClinical Pharmacist2007 β€” 2008Amman,Jordan

Education

  1. Wharton Executive EducationInvestment Strategies and Portfolio Management
  2. University of WashingtonExecutive Education, Foster School of Business2014 β€” 2015
  3. Washington State UniversityPhD, molecular pharmacology & toxicology2008 β€” 2011
  4. University of JordanPharmacy2003 β€” 2008

Skills & more

Institutional Investing8Hedge Funds8Behavioral Finance6Entrepreneurship29Pharmaceutical Industry39Clinical Development32Biotechnology92Drug Discovery14Lifesciences12Life Sciences53Project Management4Drug Development6
+2 moreTeamworkTeaching

Languages Arabic Β· English

From Leen's professional profile.

Same school

Shared employers

Investments

Board seats

Inherent BiosciencesPersephone Biosciences

Per the firm's website.

Colleagues at Propel Bio Partners